| # | Drug | Count |
|---|---|---|
| 0 | CLOZAPINE | 425 |
| 1 | PREDNISONE | 197 |
| 2 | METHOTREXATE SODIUM | 191 |
| 3 | ADALIMUMAB | 185 |
| 4 | METHOTREXATE | 166 |
| 5 | RITUXIMAB | 164 |
| 6 | ACETAMINOPHEN | 163 |
| 7 | LEFLUNOMIDE | 151 |
| 8 | ETANERCEPT | 148 |
| 9 | PANTOPRAZOLE | 145 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | MEFENAMIC ACID | 27 | 0.0122 |
| 1 | DARIFENACIN HYDROBROMIDE | 8 | 0.0092 |
| 2 | INFLIXIMAB-DYYB | 29 | 0.0084 |
| 3 | DIFLUNISAL | 5 | 0.0062 |
| 4 | PAMIDRONATE DISODIUM | 20 | 0.0059 |
| 5 | AMISULPRIDE | 33 | 0.0054 |
| 6 | ALEMTUZUMAB | 91 | 0.0047 |
| 7 | DIMENHYDRINATE | 44 | 0.0041 |
| 8 | TRABECTEDIN | 9 | 0.0038 |
| 9 | ERGOCALCIFEROL | 101 | 0.0034 |
| # | Drug class | Count |
|---|---|---|
| 0 | Atypical Antipsychotic [EPC] | 498 |
| 1 | Corticosteroid [EPC] | 365 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 327 |
| 3 | Tumor Necrosis Factor Blocker [EPC] | 232 |
| 4 | CD20-directed Cytolytic Antibody [EPC] | 176 |
| 5 | Folate Analog Metabolic Inhibitor [EPC] | 168 |
| 6 | Aminosalicylate [EPC] | 161 |
| 7 | Antirheumatic Agent [EPC] | 151 |
| 8 | Interleukin-6 Receptor Antagonist [EPC] | 141 |
| 9 | Vitamin C [EPC] | 139 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 9 | 0.0131 |
| 1 | CD52-directed Cytolytic Antibody [EPC] | 91 | 0.0047 |
| 2 | Dopamine-2 Receptor Antagonist [EPC] | 33 | 0.0042 |
| 3 | Provitamin D2 Compound [EPC] | 101 | 0.0034 |
| 4 | Guanylate Cyclase-C Agonist [EPC] | 5 | 0.0024 |
| 5 | Interferon alfa-2b [EPC] | 4 | 0.0022 |
| 6 | Plasma Volume Expander [EPC] | 5 | 0.0016 |
| 7 | Aminosalicylate [EPC] | 161 | 0.0016 |
| 8 | Antirheumatic Agent [EPC] | 151 | 0.0014 |
| 9 | Interleukin-17A Antagonist [EPC] | 42 | 0.0011 |